Security key
696389402
PALISADE BIO, INC. - Common Stock, $0.01 par value per share (PALI)
CUSIP: 696389402
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Total 13F shares
- 30,078
- Total 13F value
- $135,352
- Share change
- +30,078
- SEC-reported price per share
- $4.50
- Number of holders
- 7
- Value change
- +$135,352
- Number of buys
- 7
- Shares outstanding
- 173,216,426
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
7
Top holders
8
PALI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
PALISADE BIO, INC. SEC filings
PALISADE BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 696389402
Recent filing periods:
Ownership snapshot
Top reported holders of PALI - PALISADE BIO, INC. - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Yuma Regional Medical Center
Disclosed value leader
Yuma Regional Medical Center
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $925,331
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Yuma Regional Medical Center has the largest disclosed position value at $925.3K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Yuma Regional Medical Center's linked filing trail.
Disclosed position value
Top 5
Yuma Regional Medical Center
$925.3K
ARMISTICE CAPITAL, LLC
$287.4K
Thomas Hallam
$29.4K
VANGUARD GROUP INC
$27.2K
Marex Group plc
$14.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Yuma Regional Medical Center |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$925,331
1,814,375 shares
|
— | 19 Aug 2021 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
—
class O/S missing
|
$287,352
720,000 shares
|
— | 31 Mar 2024 |
| Thomas Hallam |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$29,372
137,592 shares
mixed-class rows
|
— | 16 Aug 2022 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$27,160
68,054 shares
|
— | 31 Mar 2024 |
| Marex Group plc |
13F
Company
|
—
class O/S missing
|
$14,271
35,759 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$13,748
34,448 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
30,078
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
87
Q2 2024 holders
7
Holder diff
-80
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend